Merck Animal Health signed an agreement with the Department of Medical Microbiology of the University Medical Center Utrecht and the Faculty of Veterinary Medicine of Utrecht University to develop vaccination strategies against bacterial udder infections (mastitis) in dairy cattle.

The project is titled “Evasion Molecules in Bovine Mastitis Vaccines” and its objective is to develop a series of vaccines against difficult to treat infections with certain bacteria known to cause bovine mastitis. The project is part of the ALTernatives for ANTibiotics program that is coordinated by Immuno Valley, a public-private research consortium.